Amwell makes grant to new employees under inducement plan
Rhea-AI Summary
Amwell (NYSE: AMWL) granted restricted stock units (RSUs) covering an aggregate 6,679 shares of Class A common stock to two new non-executive employees on August 7, 2026, as a material inducement to join the company.
According to Amwell, 25% of each grant vests on the first anniversary of the grant date, with the remaining 75% vesting in substantially equal quarterly installments thereafter, and full vesting occurring on the first day of the month following the 48‑month anniversary. The awards were approved by the Compensation Committee under American Well Corporation’s 2024 Inducement Plan and rely on the employment inducement exemption in NYSE Rule 303A.08, with this press release issued to meet that rule’s public announcement requirement.
Positive
- None.
Negative
- None.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Aug 04 | Q2 earnings report | Positive | +24.9% | Revenue reached guidance high end and full-year outlook improved |
| Jul 24 | Earnings date notice | Neutral | +0.4% | Company scheduled its second-quarter operating results release |
| May 18 | Clinical study results | Positive | +2.5% | Study reported lower mental-disorder prevalence over two years |
| May 11 | Investor conference participation | Neutral | -3.2% | Executives participated in the Needham technology conference |
| May 05 | Q1 earnings report | Neutral | +12.4% | Company announced first-quarter financial results and webcast |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Amwell's recent earnings and study announcements were followed by positive 24-hour reactions, while a conference announcement was followed by a negative reaction.
Key Terms
rsus financial
employment inducement exemption regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
BOSTON, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, announces that on August 7, Amwell made grants of RSUs covering an aggregate of 6,679 shares of its Class A common stock to two new non-executive employees. The grants were offered as material inducement to the employees’ entry into employment with Amwell. Subject to each employee’s continued employment through the applicable vesting date,
The grants described in this press release were approved by the Compensation Committee of the Amwell’s Board of Directors pursuant to American Well Corporation’s 2024 Inducement Plan and made in reliance on the employment inducement exemption under the NYSE Listed Company Manual Rule 303A.08. Amwell is issuing this press release to satisfy the public announcement requirement of Rule 303A.08.
About Amwell
Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. We use technology to provide patients with better access to more convenient, affordable and effective care. The Amwell platform includes software and services that power many clinical programs from Amwell and our growing number of partners. Our platform allows patients to experience unified, personalized and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programs become available, we offer integrated, future-ready, consistent solutions. The Amwell platform is proven, operating at a large scale, enabling care for millions of patients and their sponsors while delivering dependable outcomes. For two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or LinkedIn.
Media:
Press@amwell.com
Investor:
Asher Dewhurst
amwell@icrhealthcare.com
